Company / Total Assets
Eloxx Pharmaceuticals, Inc. Total Assets History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.7M
FY2025
5-year range
$1.7M / $33.3M
FY2021-FY2025
Trend
-81.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $33M in FY2014 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 10-year CAGR of -21.6%.
Declined from $20M to $2M over the past 10 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -21.6%
Key checks
Key Insights
- Eloxx Pharmaceuticals, Inc.'s total assets has declined for 3 consecutive years.
- In FY2025, total assets decreased 81.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7M | -81.4% |
| FY2016 | $9.2M | -52.8% |
| FY2015 | $19.5M | -41.4% |
| FY2014 | $33.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026